Angiopoietin-2: An Emerging Tie to Pathological Vessel Enlargement

Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):3-5. doi: 10.1161/ATVBAHA.121.317102. Epub 2021 Nov 11.

Authors

Negar Khosraviani^#^{1

2}, Ruilin Wu^#^{1

2}, Jason E Fish^{1

2

3}

Affiliations

¹ Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada (N.K., R.W., J.E.F.).
² Toronto General Hospital Research Institute (N.K., R.W., J.E.F.), University Health Network, Ontario, Canada.
³ Peter Munk Cardiac Centre (J.E.F.), University Health Network, Ontario, Canada.

^# Contributed equally.

PMID: 34758631
DOI: 10.1161/ATVBAHA.121.317102

No abstract available

Keywords: Editorials; GNAQ; angiopoietin-2; capillary malformation; somatic mutation; vessel enlargement.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Angiopoietin-1
Angiopoietin-2* / genetics
Receptor, TIE-2*

Substances

Angiopoietin-1
Angiopoietin-2
Receptor, TIE-2

Grants and funding

PJT 155922/CIHR/Canada